|
業務類別
|
Drug Manufacturers - General |
|
業務概覽
|
Organon & Co is a science-based pharmaceutical company that develops and delivers health solutions through a portfolio of prescription therapies within women's health, biosimilars, and established brands. The Company's operations include the following product portfolio: Women's health, Biosimilars and Established medicines. Geographically, it derives a majority of its revenue from Europe and Canada followed by the United States and then Asia Pacific and Japan. The company generates the majority of its revenue from the Established Brands product portfolio. |
| 公司地址
| 30 Hudson Street, Floor 33, Jersey City, NJ, USA, 07302 |
| 電話號碼
| +1 551 430-6900 |
| 傳真號碼
| -- |
| 公司網頁
| https://www.organon.com |
| 員工數量
| 10000 |
| Mr. Daniel Karp |
Executive Vice President, Corporate Development |
-- |
25/04/2025 |
| Ms. Lynette Holzbaur |
Senior Vice President, Finance and Corporate Controller |
-- |
24/02/2026 |
| Mr. Matthew M. Walsh |
Executive Vice President, Chief Financial Officer and Principal Accounting Officer |
美元 900.00K |
24/02/2026 |
| Mr. Vittorio Nisita |
Executive Vice President and Head of Enterprise Services and Solutions |
-- |
25/04/2025 |
| Mr. Joseph T. Morrissey, Jr |
Interim Chief Executive Officer, Executive Vice President and Head of Manufacturing and Supply |
美元 750.00K |
24/02/2026 |
| Mr. Kirke Weaver |
Executive Vice President, General Counsel and Corporate Secretary |
-- |
25/04/2025 |
| Ms. Kathryn DiMarco |
Senior Vice President and Corporate Controller |
-- |
28/02/2025 |
| Mr. Aaron Falcione |
Executive Vice President and Chief Human Resources Officer |
-- |
25/04/2025 |
| Ms. Rachel A. Stahler |
Executive Vice President and Chief Digital and Growth Officer |
-- |
25/04/2025 |
| Dr. Juan Camilo Arjona Ferreira, M.D. |
Executive Vice President, Head of Research and Development and Chief Medical Officer |
美元 650.00K |
25/04/2025 |
|
|
| Dr. Helene D. Gayle, M.D. |
Independent Director |
24/02/2026 |
| Ms. Shalini Sharp |
Independent Director |
24/02/2026 |
| Mr. Robert A. Essner |
Lead Independent Director |
24/02/2026 |
| Ms. Rochelle B. Lazarus |
Independent Director |
24/02/2026 |
| Ms. Ramona A. Sequeira |
Director |
24/02/2026 |
| Ms. Carrie S. Cox |
Executive Chairman of the Board |
24/02/2026 |
| Dr. Philip Ozuah, M.D.,PhD |
Independent Director |
24/02/2026 |
| Ms. Deborah R. Leone |
Independent Director |
24/02/2026 |
| Dr. Alan Ezekowitz, M.D.,PhD |
Independent Director |
24/02/2026 |
| Ms. Grace Puma Whiteford |
Independent Director |
24/02/2026 |
| Ms. Cynthia M. Patton |
Independent Director |
24/02/2026 |
|
|
|
|
